5-lipoxygenase-activating protein (FLAP) inhibitors

Details for Australian Patent Application No. 2008247672 (hide)

Owner Amira Pharmaceuticals, Inc.

Inventors Truong, Yen Pham; Evans, Jillian F.; Moran, Mark; Stearns, Brian Andrew; Hutchinson, John Howard; Seiders, Thomas Jon; Wang, Bowei; Roppe, Jeffrey Roger; Li, Yiwei; Zunic, Jasmine Eleanor; Prasit, Petpiboon Peppi; Arruda, Jeannie M.; Scott, Jill Melissa; Haddach, Mustapha; Stock, Nicholas Simon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008247672

PCT Pub. Number WO2008/137609

Priority 11/744,555 04.05.07 US

Filing date 1 May 2008

Wipo publication date 13 November 2008

International Classifications

C07D 209/26 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/04 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/137609 Priority application(s): WO2008/137609

10 November 2011 Assignment before Grant

  Amira Pharmaceuticals, Inc. The application has been assigned to Panmira Pharmaceuticals, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247680-Use of cyclosporines in the treatment of patients with intraocular lenses

2008247668-Pyrimidine derivatives and compositions as c-kit and PDGFR kinase inhibitors